Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
—
total disclosed, rounds participated
Stages
A Round, Pre-Seed, Seed
About
New Gate Capital is a venture capital and private equity firm with offices in Jerusalem, Tel Aviv, and London. The firm focuses on early-stage technology companies in Israel, providing its partners with access to proprietary deal flow and investment opportunities. They aim to invest in companies trusted by leading VCs and corporates.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences4
Cyber Security1
Industrial Technologies1
Agriculture & Food Technologies1
Business Software1
Energy Tech1
Funds · 3
- Opportunity Fund — $1 Nov 2025
- NGC Two — $12M Jan 2023
- NGC ONE — $60M Jan 2022
Q&A
- What is New Gate Capital's primary geographic focus for investments?
- New Gate Capital is headquartered in Tel Aviv-Yafo, Israel, and focuses its investment activities within Israel.
- What investment stages does New Gate Capital typically target?
- New Gate Capital primarily invests in Pre-Seed, Seed, and A Round stages.
- Which funds has New Gate Capital raised?
- New Gate Capital has raised three funds: NGC ONE, which closed in January 2022 with $60M, NGC Two, which closed in January 2023 with $12M, and Opportunity Fund.
- Who are the co-founders of New Gate Capital?
- New Gate Capital was co-founded by Alexander Shilman, who serves as Co-founder & General Partner, and Rafael Kozlov, who is Co-founder & Operational Partner.
- What are some of New Gate Capital's recent portfolio companies?
- New Gate Capital's recent portfolio includes NAKI, which raised $1.5M in a Seed round in 2022, and Neurobrave, which secured $3M in a Seed round in 2020.
- In which sectors does New Gate Capital show a concentration of investments?
- New Gate Capital shows a concentration in Health Tech & Life Sciences, with four portfolio companies in this sector. Other sectors include Cyber Security and Industrial Technologies.
- Can you name a portfolio company in the Health Tech & Life Sciences sector?
- New Gate Capital has invested in Latica, an AI-based Data Collaboration Platform for the Healthcare Community, which raised $12M in an A Round, and NanoGhost, a Naturally Targeted Drug Platform, which raised $9M in a Seed round.
- What is New Gate Capital's investment thesis?
- New Gate Capital leverages its network to access top investment opportunities in Israel, focusing on proprietary deal flow with proper valuations.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | newgate.capital/ |
|---|---|
| linkedin.com/company/81844734 |
Identifiers & details
| Founded | 2022 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | newgate.capital |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|